The SCAPIS study design outlines a comprehensive approach using advanced imaging and omics in 30,000 Swedish individuals to improve cardiopulmonary risk prediction and understand disease mechanisms.
Answers are grounded in this paper and cite their sources.
Pilot feasibility supports large-scale SCAPIS launch; leaves open whether imaging-omics will improve cardiopulmonary risk prediction.
Cardiopulmonary diseases are major causes of death worldwide, but currently recommended strategies for diagnosis and prevention may be outdated because of recent changes in risk factor patterns. The Swedish CArdioPulmonarybioImage Study (SCAPIS) combines the use of new imaging technologies, advances in large-scale 'omics' and epidemiological analyses to extensively characterize a Swedish cohort of 30 000 men and women aged between 50 and 64 years. The information obtained will be used to improve risk prediction of cardiopulmonary diseases and optimize the ability to study disease mechanisms. A comprehensive pilot study in 1111 individuals, which was completed in 2012, demonstrated the feasibility and financial and ethical consequences of SCAPIS. Recruitment to the national, multicentre study has recently started.
No takes yet. Share an insight, caveat, or question.
Bergström et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: